CellWell record HH-3628
Meta-analysis of DHA and EPA supplementation on cardiovascular outcomes and atrial fibrillation risk
Not captured in abstract review
Pharmacology Research & Perspectives ยท 2026
In plain language
Selected high-dose purified EPA subgroups had MACE signals -- No broad MACE or atrial-fibrillation benefit for combined moderate-dose EPA+DHA; high doses may increase AF
- Evidence
- Emerging
- Design
- Meta-analysis
Cite this record: https://thecellwell.org/studies/HH-3628
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.